Mai Capital Management Csl LTD Transaction History

Mai Capital Management

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$80.15 - $92.62 $340,717 - $393,727	-4,251 Reduced 57.05%	3,201 $258,000
Q2 2023 Aug 02, 2023	BUY	$91.49 - $104.64 $681,783 - $779,777	7,452 New	7,452 $687,000
Q2 2022 Jul 19, 2022	SELL	$87.94 - $101.67 $7,562 - $8,743	-86 Reduced 0.82%	10,364 $953,000
Q1 2022 May 10, 2022	BUY	$85.56 - $107.12 $32,683 - $40,919	382 Added 3.79%	10,450 $1.04 Million
Q4 2021 Feb 11, 2022	SELL	$97.41 - $116.74 $1,168 - $1,400	-12 Reduced 0.12%	10,068 $1.07 Million
Q3 2021 Nov 12, 2021	BUY	$101.72 - $114.56 $14,240 - $16,038	140 Added 1.41%	10,080 $1.06 Million
Q2 2021 Jul 19, 2021	SELL	$100.62 - $116.66 $15,897 - $18,432	-158 Reduced 1.56%	9,940 $1.06 Million
Q1 2021 May 10, 2021	SELL	$95.11 - $111.11 $21,019 - $24,555	-221 Reduced 2.14%	10,098 $1.02 Million
Q4 2020 Feb 16, 2021	BUY	$101.34 - $117.74 $4,256 - $4,945	42 Added 0.41%	10,319 $1.14 Million
Q3 2020 Oct 26, 2020	SELL	$95.79 - $111.95 $8,142 - $9,515	-85 Reduced 0.82%	10,277 $1.06 Million
Q2 2020 Jul 27, 2020	SELL	$90.75 - $104.91 $52,816 - $61,057	-582 Reduced 5.32%	10,362 $1.03 Million
Q4 2019 Feb 03, 2020	BUY	$77.9 - $98.54 $4,128 - $5,222	53 Added 0.49%	10,944 $1.06 Million
Q3 2019 Oct 29, 2019	BUY	$74.21 - $82.92 $50,091 - $55,971	675 Added 6.61%	10,891 $864,000
Q2 2019 Aug 15, 2019	BUY	$68.24 - $75.87 $697,139 - $775,087	10,216 New	10,216 $774,000

153K

Ticker CSLLY
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 964,432,000
Market Cap $87.1B
Description
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plas...

Get notified when there are updates to the investment portfolio of Mai Capital Management, based on Form 13F filings with the SEC.

Stay updated on Mai Capital Management with notifications on news.